Get the content you want anytime you want.

Select coverage from ASM Microbe 2017 Conference is included below:

Investigating <i>Pseudomonas</i> Susceptibility to Ceftolozane/tazobactam
Jason Pogue, PharmD, BCPS-ID, explains his team’s study regarding the susceptibility of Pseudomonas isolates to ceftolozane/tazobactam.
What is the Best Way to Determine an Alternative Agent During a Drug Shortage?
Milena McLaughlin, PharmD, MSc, explains the best way to determine an alternative agent during a drug shortage.
Can Antimicrobial Photodynamic Therapy Complement Antimicrobial Chemotherapy?
Caetano Sabino, BSc, discusses how antimicrobial photodynamic therapy could be used to complement antimicrobial chemotherapy in order to manage drug-resistant infections.
How Restrictions on Commercial Automated Susceptibility Testing Affects Patient Care
Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how restrictions on commercial automated susceptibility testing can affect patient care.
New Therapies on Horizon May Positively Impact PrEP Adherence & Treatment
Kenneth Mayer, MD, discusses new therapies that may have a positive impact on pre-exposure prophylaxis adherence and treatment.
What is The Fact-Track Cities Initiative?
Benjamin Young, MD, PhD, explains the Fast-Track Cities initiative.
Is Photodynamic Therapy a Cost-Effective Treatment Option?
Caetano P. Sabino, BSc, PhD Student, explains if photodynamic therapy a cost-effective treatment option.
Why Is It Important to Look at Cross-Reactivity Among Beta-Lactams?
Meghan Jeffres, PharmD, explains the importance of discussing cross-reactivity among beta-lactams.
We break down our top HIV news stories of 2017. Did you read them all?